Perspectives on how novel lipid-lowering therapies may help address current unmet needs

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the unmet needs in patients at high risk of ASCVD and how novel lipid-lowering therapies may help  The multidisciplinary team Endocrinologist: Professor Lawrence Leiter, Canada Cardiologist: Dr Constantine Kosmas, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This medical education is provided by touchIME. For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ascvd-risk//